Estados financieros detallados de Cellectar Biosciences, Inc. (CLRB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.35, CLRB presenta beneficios negativos (P/E no significativo) y un ROE del -165.71%. La capitalización bursátil es de $19M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $356665 | $1.5M | $82265 | $189360 | 0 | 0 | 0 | 0 | 0 | $213597 |
| Beneficio Bruto | -$356665 | -$1.5M | -$82265 | -$189360 | 0 | 0 | 0 | 0 | 0 | -$213597 |
| I+D | $4.8M | $9.5M | $6.8M | $9.0M | $10.1M | $17.6M | $19.2M | $27.3M | $26.1M | $11.5M |
| Generales y Administrativos | $4.7M | $4.1M | $4.8M | $5.0M | $5.1M | $6.5M | $9.6M | $11.7M | $25.6M | $11.5M |
| Gastos Operativos | $9.4M | $13.6M | $11.7M | $14.0M | $15.3M | $24.1M | $28.8M | $39.0M | $51.8M | $22.8M |
| Beneficio Operativo | -$9.4M | -$13.6M | -$13.3M | -$14.2M | -$15.3M | -$24.1M | -$28.8M | -$39.0M | -$51.8M | -$23.0M |
| EBITDA | -$9.1M | -$12.1M | -$13.2M | -$13.9M | -$14.9M | -$24.0M | -$31.7M | -$42.6M | -$44.2M | -$21.6M |
| Gastos por Intereses | $7897 | $16605 | $29687 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$6.2M | -$13.6M | -$13.2M | -$14.1M | -$15.1M | -$24.1M | -$31.9M | -$42.8M | -$44.5M | -$21.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | -$60000 | -$60000 | $66000 | 0 |
| Beneficio Neto | -$6.2M | -$13.6M | -$13.2M | -$14.1M | -$15.1M | -$24.1M | -$31.8M | -$42.8M | -$44.6M | -$21.8M |
| BPA | $-6420.00 | $-3210.00 | $-1567.96 | $-550.86 | $-228.55 | $-130.35 | $-135.18 | $-104.99 | $-36.52 | $-8.35 |
| BPA Diluido | $-6420.00 | $-3210.00 | $-1567.96 | $-550.86 | $-228.55 | $-130.35 | $-135.18 | $-104.99 | $-41.89 | $-8.35 |
| Acciones en Circulación (Diluidas) | $1455 | $4677 | $9873 | $25583 | $66042 | $185052 | $235188 | $407385 | $1.2M | $2.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | $110018 | 0 |
| Beneficio Operativo | -$4.9M | -$5.7M | -$5.8M | -$7.2M |
| EBITDA | -$4.4M | -$5.2M | -$5.8M | -$6.9M |
| Beneficio Neto | -$4.4M | -$5.3M | -$5.7M | -$6.9M |
| BPA | $-1.41 | $-1.25 | $-1.33 | $-0.57 |
| BPA Diluido | $-1.41 | $-1.25 | $-1.33 | $-0.57 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $11.4M | $10.0M | $13.3M | $10.6M | $57.2M | $35.7M | $19.9M | $9.6M | $23.3M | $13.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $12.2M | $10.5M | $14.0M | $11.4M | $57.9M | $36.6M | $20.5M | $10.5M | $24.3M | $14.0M |
| Inmovilizado Material | $1.4M | $244713 | $543339 | $783924 | $638347 | $549135 | $978975 | $1.6M | $1.2M | $910076 |
| Fondo de Comercio | $1.7M | $1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $15.3M | $12.9M | $15.1M | $12.3M | $58.7M | $37.2M | $21.6M | $12.1M | $25.5M | $15.0M |
| Cuentas por Pagar | $1.4M | $1.9M | $1.5M | $1.3M | $1.4M | $1.4M | $2.6M | $5.6M | $4.1M | $1.4M |
| Deuda a Corto | $86591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $2.1M | $1.6M | $2.8M | $3.6M | $4.0M | $11.5M | $25.4M | $9.4M | $4.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.8M | $2.1M | $1.8M | $3.2M | $3.9M | $4.2M | $12.1M | $25.9M | $11.2M | $5.1M |
| Reservas | -$70.8M | -$84.3M | -$97.6M | -$111.7M | -$126.8M | -$150.9M | -$160.0M | -$202.8M | -$247.3M | -$269.1M |
| Patrimonio Neto | $13.5M | $10.8M | $13.3M | $9.1M | $54.8M | $33.0M | $9.5M | -$13.8M | $14.3M | $9.9M |
| Deuda Total | $94567 | $5249 | $2213 | $527529 | $421644 | $301741 | $603828 | $552982 | $494003 | $409586 |
| Deuda Neta | -$11.4M | -$10.0M | -$13.3M | -$10.1M | -$56.7M | -$35.4M | -$19.3M | -$9.0M | -$22.8M | -$12.8M |
| Capital Circulante | $10.6M | $8.4M | $12.3M | $8.6M | $54.4M | $32.6M | $9.0M | -$14.9M | $14.9M | $9.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $12.6M | $13.2M | $8.3M | $34.0M |
| Activos Totales | $14.6M | $15.0M | $11.1M | $36.6M |
| Pasivos Totales | $5.2M | $5.1M | $6.4M | $6.8M |
| Patrimonio Neto | $9.4M | $9.9M | $4.7M | $29.9M |
| Deuda Total | $431929 | $409586 | $1.5M | $1.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$6.2M | -$13.6M | -$13.2M | -$14.1M | -$15.1M | -$24.1M | -$28.6M | -$42.8M | -$44.6M | -$21.8M |
| Amortizaciones | $356665 | $1.5M | $82265 | $132798 | $141453 | $149915 | $148435 | $192375 | $291653 | $213597 |
| Compensación en Acciones | $529159 | $758757 | $721209 | $866791 | $467541 | $1.1M | $1.5M | $2.4M | $4.3M | $2.3M |
| Cambio en Capital Circulante | $273813 | $259259 | -$569053 | $1.4M | $671239 | $198761 | $1.7M | $3.5M | -$1.7M | -$3.1M |
| Flujo de Caja Operativo | -$8.3M | -$11.0M | -$11.4M | -$11.7M | -$13.9M | -$22.6M | -$25.2M | -$32.4M | -$47.6M | -$23.1M |
| Inversiones (CapEx) | -$72251 | -$346703 | -$384993 | -$24542 | -$62353 | -$141361 | -$225971 | -$864038 | -$104199 | -$5880 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.4M | -$11.4M | -$11.8M | -$11.7M | -$14.0M | -$22.7M | -$25.4M | -$33.2M | -$47.7M | -$23.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.3M | -$4.3M | -$4.8M | -$6.0M |
| Inversiones (CapEx) | $1 | -$5884 | -$3375 | 0 |
| Flujo de Caja Libre | -$4.3M | -$4.4M | -$4.8M | -$6.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | 0 | 0 | $428306 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -119.4% | +2.4% | -6.4% | -7.1% | -59.8% | -31.8% | -34.5% | -4.2% | +51.1% |
| Crecimiento BPA (anual) | | +50.0% | +51.2% | +64.9% | +58.5% | +43.0% | -3.7% | +22.3% | +65.2% | +77.1% |
| Cambio en Acciones (anual) | | +221.4% | +111.1% | +159.1% | +158.1% | +180.2% | +27.1% | +73.2% | +203.9% | +110.7% |
| Crecimiento FCF (anual) | | -36.1% | -4.0% | +0.9% | -19.4% | -62.3% | -12.1% | -30.6% | -43.5% | +51.5% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.2% | 0.1% | -0.1% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5741.90 | $-2430.40 | $-1197.92 | $-458.05 | $-211.91 | $-122.72 | $-108.20 | $-81.60 | $-38.52 | $-8.87 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1455 | $4677 | $9873 | $25583 | $66042 | $185052 | $235188 | $407385 | $1.2M | $2.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -165.71% |
| Rentabilidad sobre capital invertido | -74.93% |
| Rentabilidad sobre activos | -60.93% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 6.66 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -28.56 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.57 | -1.28 | -0.30 | -1.23 | -2.73 | -1.52 | -0.38 | -0.79 | -0.25 | -0.35 |
| P/VC | 0.39 | 1.79 | 0.35 | 1.91 | 0.75 | 1.11 | 1.27 | -2.46 | 0.77 | 0.78 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |